A Study in Pediatric Participants With Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if duloxetine [30-120 milligrams (mg)] given once a
day by mouth for 10 weeks to children and adolescents, is better than placebo when treating
Generalized Anxiety Disorder (GAD).